Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan;25(1):77-83.
doi: 10.1016/j.nec.2013.08.011. Epub 2013 Oct 10.

Central neuromodulation for refractory pain

Affiliations
Review

Central neuromodulation for refractory pain

Nina Z Moore et al. Neurosurg Clin N Am. 2014 Jan.

Abstract

Chronic neuropathic pain affects 8.2% of adults, extrapolated to roughly 18 million people every year in the United States. Patients who have pain that cannot be controlled with pharmacologic management or less invasive techniques can be considered for deep brain stimulation or motor cortex stimulation. These techniques are not currently approved by the Food and Drug Administration for chronic pain and are, thus, considered off-label use of medical devices for this patient population. Conclusive effectiveness studies are still needed to demonstrate the best targets as well as the reliability of the results with these approaches.

Keywords: Deep brain stimulation (DBS); Motor cortex stimulation (MCS); Neuromatrix; Neuromodulation; Pain.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
DBS targets for pain management. (A) More traditional DBS targets aimed at treating the sensory-discriminative component of pain. The image shows the preoperative magnetic resonance imaging (MRI) and corresponding lead (model 3387, Medtronic, Minneapolis, MN) locations for a patient with one DBS lead in the VPL/VPM and a second DBS lead in the PVG. Both sagittal and coronal slices are shown near the distal ends of the leads. The patient-specific lead locations and trajectories were determined using the software Cicerone v1.3. (B) A recently proposed DBS target aimed at treating the affective-motivational component of pain. The image shows an oblique coronal view of the postoperative MRI for a patient with bilateral DBS leads (Medtronic model 3391) implanted in the ventral capsule and ventral striatal (VC/VS) area. It is possible to see the 4 electrodes in the right hemisphere as well as the distal end of the DBS lead implanted in the left hemisphere.

References

    1. Torrance N, Smith BH, Bennett MI, et al. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain. 2006;7(4):281–9. - PubMed
    1. United States Census Bureau. The 2012 statistical abstract. [Accessed on May 16, 2013];The national data book, “Table 7: resident population by sex and age: 1980 to 2010”. 2013 Available at: http://www.census.gov/compendia/statab/2012/tables/12s0007.pdf.
    1. Machado A, Kopell BH, Rezai AR. Chronic electrical stimulation for refractory chronic pain. In: Star PA, Barbaro NM, Larson PS, editors. Neurosurgical operative atlas. Functional neurosurgery. 2. New York: Thieme Medical Publishers; 2009. p. 134.
    1. Hirayama T, Tsubokawa T, Katayama Y, et al. Chronic changes in activity of thalamic lemniscal relay neurons following spino-thalamic tractotomy in cats: effects of motor cortex stimulation. Pain. 1990;41:S273.
    1. Yamasiro K, Mukawa J, Terada Y, et al. Neurons with high-frequency discharge in the central nervous system in chronic pain. Stereotact Funct Neurosurg. 1994;62:290–4. - PubMed

MeSH terms